Successful treatment of Bing-Neel syndrome using intrathecal chemotherapy and systemic combination chemotherapy followed by BEAM auto-transplant: A case report and review of literature

Clinical Lymphoma, Myeloma and Leukemia

Volumn 13, Issue 4, 2013, Pages 502-506

  Abdallah, Al Ola ^a   Atrash, Shebli ^a   Muzaffar, Jameel ^a   Abdallah, Motaz ^b   Kumar, Manoj ^c   Van Rhee, Fritz ^a   Barlogie, Bart ^a  

^a Myeloma Institute for Research and Therapy   (United States)

^b UNIVERSITY OF JORDAN   (Jordan)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Autologous stem cell transplant; Bing Neel syndrome; Intrathecal chemotherapy; Waldenstr m's macroglobulinemia

Indexed keywords

BORTEZOMIB; CARMUSTINE; CD19 ANTIGEN; CD20 ANTIGEN; CISPLATIN; CLADRIBINE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; HYDROCORTISONE; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN M; MELPHALAN; METHOTREXATE; RITUXIMAB; THALIDOMIDE;

ADULT; AMNESIA; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; B LYMPHOCYTE; BING NEEL SYNDROME; BLURRED VISION; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; CELL POPULATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM DISEASE; CONTRAST ENHANCEMENT; DRUG EFFICACY; FATIGUE; FLOW CYTOMETRY; HEADACHE; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPHENOTYPING; LEPTOMENINX; LUMBAR SPINE; LYMPHOCYTE; LYMPHOID CELL; MAINTENANCE THERAPY; MALE; MAST CELL; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; NAUSEA; NIGHT SWEAT; NUCLEAR MAGNETIC RESONANCE IMAGING; OMMAYA RESERVOIR; PLASMA CELL; PLASMAPHERESIS; RECURRENT FEVER; SKULL IRRADIATION; SPINAL ROOT; SYSTEMIC THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING; WALDENSTROEM MACROGLOBULINEMIA; WEAKNESS;

AUTOLOGOUS STEM CELL TRANSPLANT; BING-NEEL SYNDROME; INTRATHECAL CHEMOTHERAPY; WALDENSTRÖM'S MACROGLOBULINEMIA;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CISPLATIN; DEXAMETHASONE; DOXORUBICIN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INJECTIONS, SPINAL; MALE; MIDDLE AGED; THALIDOMIDE; WALDENSTROM MACROGLOBULINEMIA;

EID: 84880710730     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2013.03.002     Document Type: Article

References (26)

1. S.H. Swerdlow, E. Campo, and N.L. Harris WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th ed. 2008 International Agency for Research on Cancer Lyon, France
2. L.J. Herrinton, and N.S. Weiss Incidence of Waldenstrom's macroglobulinemia Blood 82 1993 3148 3150 (Pubitemid 23334943)
3. F.D. Groves, L.B. Travis, and S.S. Devesa Waldenström's macroglobulinemia: incidence patterns in the United States, 1988-1994 Cancer 82 1998 1078 1081 (Pubitemid 28136520)
4. B.W. Scheithauer, L.J. Rubinstein, and M.M. Herman Leukoencephalopathy in Waldenstrom's macroglobulinemia: immunohistochemical and electron microscopic observations J Neuropathol Exp Neurol 43 1984 408 425 (Pubitemid 14089421)
5. R. Edgar, and T.F. Dutcher Histopathology of the Bing-Neel syndrome Neurology 11 1961 239 245
6. J. Bing, and A.V. Neel Two cases of hyperglobulinaemia with affection of the central nervous system on a toxi-infectious basis Acta Med Scand 88 1936 492 506
7. I.M. Ghobrial, M.A. Gertz, and R. Fonseca Waldenstrom macroglobulinaemia Lancet Oncol 4 2003 679 685
8. O. Vula, and P. Merhaien Cerebral reticuloplasmacytosis with hyperglobulinemia. Its relation to the Bing-Neel syndrome Eur Neurol 7 1972 155 168
9. L.G. Logothetis, P. Silvertein, and J. Coe Neurologic aspects of Waldenstrom's macroglobulinemia. Report of a case Arch Neurol 3 1960 564 573
10. J.J. Torrey, and S.B. Katokkar Treatable meningeal involvement in Waldenstrom's macroglobulinemia Ann Intern Med 101 1984 345 347 (Pubitemid 14033786)
11. M.T. Bhatti, C. Yuan, and W. Winter Bilateral sixth nerve paresis in the Bing-Neel syndrome Neurology 64 2005 576 577 (Pubitemid 40189894)
12. J.P. Neau, F. Guilhot, and P. Dumas Central neurologic forms of Waldenstrom's disease Bing-Neel syndrome. 3 cases [in French] Rev Neurol (Paris) 147 1991 56 60
13. F. Imai, K. Fujisawa, and N. Kiya Intracerebral infiltration by monoclonal plasmacytoid cells in Waldenstrom's macroglobulinenemia-case report Neurol Med Chir (Tokyo) 35 1995 575 579
14. J. Delgado, M.A. Canales, and B. Garcia Radiation therapy and combination of cladribine, cyclophosphamide, and prednisone as treatment of Bing-Neel syndrome: case report and review of the literature Am J Hematol 69 2002 127 131 (Pubitemid 34111165)
15. H.D. Kim, K.C. Shin, and H.S. Cho Therapeutic experience of Bing-Neel syndrome associated with Waldenstrom's macroglobulinenemia J Korean Med Sci 22 2007 1079 1081
16. O. Fain, B. Wechsler, and M. Vidailhet Involvement of central nervous system disclosing Waldenstrom's disease: demonstration of intrathecal secretion of immunoglobulin M [in French] Rev Med Interne 13 1992 58 60
17. T. Jammer, C. Mann, and E. Delhom Bing-Neel syndrome revealed by normal pressure hydrocephalus. Unusual clinical/course of Waldenstrom disease [in French] Presse Med 19 1990 1992
18. R. Quilichini, T. Benderitter, and A. Lafeuillade Waldenstrom's macroglobulinenemia with cerebral lymphoproliferative involvement of tumor appearance (Bing and Neel syndrome). An anatomo-clinical case [in French] Ann Med Interne (Paris) 140 1989 25 29 (Pubitemid 19155310)
19. S.P. Treon, P. Morel, and V. Leblond Report of the Third International Workshop on Waldenstrom's macroglobulinemia Clin Lymphoma 5 2005 215 216 (Pubitemid 40614228)
20. Z. Hunter, A. Branagan, and S.T. Treon Campath-1H in Waldenström's Macroglobulinemia Blood 104 2004 4929 (abstract 104)
21. S. Treon, Z. Hunter, and J. Matous Phase II study of Bortezomib in Waldenstrom's macroglobulinemia: results of WMCTG Trial 03-248 Blood 106 2005 490 (abstract 106)
22. S.P. Treon, J.D. Soumerai, and A.R. Branagan Thalidomide and rituximab in Waldenstrom macroglobulinemia Blood 112 2008 4452 4457
23. C.I. Chen, C.T. Kouroukis, and D. White Bortezomib is active in patients with untreated or relapsed Waldenstrom's macroglobulinemia: a phase II study of the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 25 2007 1570 1575 (Pubitemid 46733084)
24. S.P. Treon, L. Ioakimidis, and J.D. Soumerai Primary therapy of Waldenstrom macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG Clinical Trial 05-180 J Clin Oncol 27 2009 3830 3835
25. M.A. Dimopoulos, C. Zervas, and A. Zomas Treatment of Waldenstrom's macroglobulinemia with rituximab J Clin Oncol 20 2002 2327 2333
26. B. Barlogie, G. Tricot, and E. Anaissie Thalidomide and hematopoietic-cell transplantation for multiple myeloma N Engl J Med 354 2006 1021 1030 (Pubitemid 43357806)